Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
Kensuke MatsushitaClément DelmasBenjamin MarchandotFrancois RoubilleNicolas LamblinGuillaume LeurentBruno LevyMeyer ElbazSebastien ChampionPascal LimFrancis SchneiderHadi KhachabAdrien CarmonaAntonin TrimailleBourenne JeremyMarie-France SerondeGuillaume SchurtzBrahim HarbaouiGerald VanzettoCaroline BiendelVincent LabbeNicolas CombaretJacques MansouratiEmmanuelle FilippiJulien MaizelHamid MerdjiBenoit LattucaEdouard GerbaudEric BonnefoyEtienne PuymiratLaurent BonelloOlivier MorelPublished in: Journal of the American Heart Association (2024)
In survivors of CS, the one-year mortality rate was significantly lower in those with triple GDMT. Therefore, this study suggests that intensive HF therapy should be considered in patients following CS.